Valued at $480m in 2013 by the Ministry of Commerce, Myanmar’s pharmaceuticals industry offers drug makers a new opportunity, particularly over-the-counter manufacturers who stand to benefit from the country’s reopening. A dramatic increase in health expenditure coupled with rising per capita income is set to see the value of the industry grow to $945m in 2015, a nearly...